Business

Crescita Therapeutics(TM) Announces the Appointment of Serge Verreault as President & CEO

Crescita Therapeutics™ Announces the Appointment of Serge Verreault as President &a...

articleCrescita Therapeutics, Inc.April 3, 20183/company/crescita-therapeutics-inc/news/crescita-therapeuticstm-announces-the-appointment-of-serge-verreault-as-president-and-ceo
Crescita Therapeutics(TM) Announces the Appointment of Serge Verreault as President & CEO

About this update from Crescita Therapeutics, Inc.

[{"type":"text","content":"\n\n\n\nCrescita Therapeutics™ Announces the Appointment of Serge Verreault as President & CEO\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nCrescita Therapeutics™ Announces the Appointment of Serge Verreault as President & CEO\nCanada NewsWire\nMISSISSAUGA, ON, April 3, 2018\n\n\n\nMISSISSAUGA, ON, April 3, 2018 /CNW/ - Crescita Therapeutics Inc. (TSX: CTX) (\"Crescita\" or the \"Company\"), a commercial dermatology company with a portfolio of non-prescription skincare products and prescription drug products for the treatment and care of skin conditions and diseases and their symptoms, today announced the appointment of Mr. Serge Verreault, Crescita's current President,  as President and CEO of the Company effective April 2, 2018. Mr. Dan Chicoine will continue as Crescita's Executive Chairman and to serve on the Company's board of directors.\n\n\n \n \n\n \n\"We are pleased that Serge will assume this new leadership role at Crescita,\" said Anthony Dobranowski, Crescita's Lead Director. \"As President of Crescita, Serge has proven himself to be a capable leader and motivator with the knowledge and experience to execute our growth strategy of building a profitable and successful North American skincare company serving both the non-prescription and prescription markets.\"\n\n\"I am very excited to assume this new position. I believe Crescita is well positioned to become a leader in skin care as we have the products and technologies to grow the business into a leading dermatological company,\" said Serge Verreault, President & CEO.\n\nPrior to joining Crescita in April 2017, Mr. Verreault worked at Valeant Canada for fourteen years in a variety of positions. Most recently, Mr. Verreault was the Executive Director of Business Development and a member of the Operating Committee. During his tenure in this role, he also served as the General Manager of Laboratoire Dr Renaud™.  Laboratoire Dr Renaud is one of the product lines that Crescita acquired as part of the INTEGA Skin Sciences Inc. acquisition in Septembe...

More updates from Crescita Therapeutics, Inc.